18F-FDG PET for Evaluation of Bone Marrow Infiltration in Staging of Lymphoma: A Meta-Analysis
Emilios E. Pakos, MD1,
Andreas D. Fotopoulos, MD2 and
John P.A. Ioannidis, MD1,3,4
1 Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
2 Department of Nuclear Medicine, University Hospital of Ioannina, School of Medicine, Ioannina, Greece
3 Biomedical Research Institute, Foundation for Research and TechnologyHellas, Ioannina, Greece
4 Department of Medicine, Institute for Clinical Research and Health Policy Studies, TuftsNew England Medical Center, Tufts University School of Medicine, Boston, Massachusetts

View larger version (17K):
[in a new window]
|
FIGURE 1. Summary SROC curve analysis shows ability of 18F-FDG PET to evaluate bone marrow infiltration in patients with lymphoma. Each study is shown by an ellipse demonstrating sensitivity and specificity of 18F-FDG PET along with lines extending to respective 95% CIs. BMB is reference standard. Ellipse axes are proportional to weight of study in specificity and sensitivity dimensions. Data are summarized with weighted (thick line) and unweighted (thin line) SROC curves.
|
|
Copyright © 2005 by the Society of Nuclear Medicine.